Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansu Abu Alex

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Blood|March 1, 2012
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapyEzhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian populationSachin David, Sukesh C Nair, G Surender Singh, et al.
Frontiers in Immunology|July 3, 2018
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-GenesisAnsu Abu Alex, Saravanan Ganesan, Hamenth Kumar Palani, et al.
Plos One|March 31, 2015
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistanceEzhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Blood|March 1, 2012
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapyEzhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian populationSachin David, Sukesh C Nair, G Surender Singh, et al.
Frontiers in Immunology|July 3, 2018
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-GenesisAnsu Abu Alex, Saravanan Ganesan, Hamenth Kumar Palani, et al.
Plos One|March 31, 2015
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistanceEzhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, et al.
Pageof 2